NCT01387737View on ClinicalTrials.gov

Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

1,299

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

TA-7284-Low

TA-7284-Low

DRUG

TA-7284-High

TA-7284-High

Trial Locations (7)

Unknown

Research site, Chugoku

Research site, Hokkaido

Research site, Kanto

Research site, Kinki

Research site, Kyushu

Research site, Shikoku

Research site, Tōhoku

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY